Quick answers
- What is Lamisil AT?
- Lamisil AT is a brand name of Terbinafine, an over-the-counter medicine. The FDA NDC Directory lists 7 Lamisil AT products in 2 strengths and forms.
- Who makes Lamisil AT?
- Karo Hlthcare holds the FDA application for Lamisil AT (NDA020980, approved March 9, 1999). 1 other company (repackagers or distributors) also list Lamisil AT products.
- Is there a generic or store brand of Lamisil AT?
- Yes. The FDA NDC Directory lists 27 other products with the same active ingredients, strength and form as a Lamisil AT product, 27 of them generic or store brands. Ask your pharmacist whether one is right for you.
- Has Lamisil AT been recalled?
- No recall linked to Lamisil AT products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Lamisil AT is
Each Lamisil AT product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Terbinafine · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| terbinafine hydrochloride 1% cream (topical) | Lamisil AT Cream, Lamisil At Terbinafine Hydrochloride | 27 products, 21 companies | DailyMed |
| terbinafine hydrochloride 1% spray (topical) | Lamisil AT | None listed | DailyMed |
Its page quotes the Drug Facts label and lists every brand and store brand: Terbinafine →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Lamisil AT
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Lamisil AT products.
- Karo Healthcare Inc.5 products
- Voyant Beauty Inc.2 products
Recalls
No recall linked to Lamisil AT products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.